Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate.

Prostate cancer Squamous cell

Journal

European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568

Informations de publication

Date de publication:
Jan 2021
Historique:
accepted: 12 11 2020
entrez: 2 8 2021
pubmed: 3 8 2021
medline: 3 8 2021
Statut: epublish

Résumé

Primary squamous cell carcinoma is a rare, aggressive disease with historically poor outcomes and no established treatment guidelines. Case reports are limited but describe multiple treatment approaches. Seeking to identify practice patterns and treatment outcomes, we used the US National Cancer Data Base to identify 66 males with locoregional primary squamous cell carcinoma of the prostate treated with surgery, chemotherapy, and/or radiotherapy between 2004 and 2015. Patients were stratified into treatment groups consisting of local therapy alone ( Squamous cell carcinoma of the prostate is an extremely rare disease. Our review of patterns of care using data from the National Cancer Data Base shows inconsistent use of combined local and systemic therapy. The small sample size for this rare disease limits any conclusions regarding survival differences, but the data suggest that a combination approach using chemotherapy in addition to surgery or radiation is a reasonable treatment option for disease confined to the prostate.

Identifiants

pubmed: 34337486
doi: 10.1016/j.euros.2020.11.008
pii: S2666-1683(20)36378-3
pmc: PMC8317810
doi:

Types de publication

Journal Article

Langues

eng

Pagination

30-33

Informations de copyright

© 2020 The Author(s).

Références

Case Rep Med. 2014;2014:860570
pubmed: 24782898
Hinyokika Kiyo. 1996 Jan;42(1):67-70
pubmed: 8686589
Future Sci OA. 2015 Nov 01;1(3):FSO18
pubmed: 28031893
Int Cancer Conf J. 2016 Oct 11;6(1):25-28
pubmed: 31149464
Nihon Hinyokika Gakkai Zasshi. 2019;110(2):129-133
pubmed: 32307381
Am J Surg Pathol. 2004 May;28(5):651-7
pubmed: 15105655
Diagn Pathol. 2011 May 31;6:46
pubmed: 21627811
Rev Urol. 2011;13(1):56-60
pubmed: 21826130
Quant Imaging Med Surg. 2012 Dec;2(4):294-5
pubmed: 23289092

Auteurs

Ryan J Hutten (RJ)

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.

Christopher R Weil (CR)

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.

Jonathan D Tward (JD)

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.

Shane Lloyd (S)

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.

Skyler B Johnson (SB)

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.

Classifications MeSH